Is the targeted drug Ponatinib included in medical insurance?

Ponatinib (Ponatinib) is a targeted therapy drug. The original drug has not yet been launched in China, so it is not included in medical insurance. Domestic patients in need may only purchase it through overseas channels. The price of the Hong Kong original version of ponatinib, 45mg*30 tablets per box, may be around 40,000 yuan (the price may fluctuate due to exchange rates), which is expensive. There are also generic ponatinib drugs produced in other countries, which are relatively cheap. The price of 45mg*30 tablets per box produced by Everest Pharmaceutical Factory in Bangladesh may be around 4,000 yuan (the price may fluctuate due to the exchange rate), and its drug ingredients are basically the same as those of the original drug.